Frontiers
US$ 20.53
semaglutide patent expiry india Indian pharma companies launch low-cost generic #VantageOnFirstpost: Semaglutide Goes Generic in
Description
The company's shares fell 3.5% in volatile premarket trading on Monday as Pfizer said it would stop developing its therapy lotiglipron.
Expert guidance, DEXA scans & RN support.
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life improvements occurring despite minimal weight changes.
Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.
